Literature DB >> 6237264

T3-Ti receptor triggering of T8+ suppressor T cells leads to unresponsiveness to interleukin-2.

A Bensussan, O Acuto, R E Hussey, C Milanese, E L Reinherz.   

Abstract

T3-associated disulphide linked heterodimers (Tin) comprised of clonally unique alpha-chains of molecular weight (MW) 49,000-54,000 and beta chains of MW 43,000 have been identified as the antigen receptors on human cytotoxic effector and inducer T-lymphocytes. Crosslinking of Ti molecules by either the appropriate nominal antigen/MHC specificity or anti-clonotypic monoclonal antibody results in clonal expansion of such cells via induction of IL-2 receptor expression, endogenous IL-2 release and IL-2-IL-2 receptor interaction. To determine whether analogous antigen receptor molecules and autocrine growth mechanisms are utilized by suppressor T-cells, we produced an anti-clonotypic monoclonal antibody against a non-cytotoxic T8+ suppressor T-cell, T8AC6, which defines a T3-associated disulphide-linked heterodimer of similar molecular weight to the above clonotypes. We find that Te-Ti triggering of suppressor clones (T8AC6, T8AC7 or T8RW) does not result in IL-2 production or T-cell proliferation and in contrast to inducer clones, also leads to a transient IL-2 unresponsive state. We suggest that such T3-Ti receptor mediated autoregulation of suppressor T-cell growth is necessary in the facilitation of initial inducer T-cell activation following antigenic perturbation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237264     DOI: 10.1038/311565a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  11 in total

1.  Genes encoding the T-cell receptor alpha and beta subunits are transcribed in an ordered manner during intrathymic ontogeny.

Authors:  H D Royer; D Ramarli; O Acuto; T J Campen; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Proliferative signals for suppressor T cells. Helper cells stimulated with pokeweed mitogen in vitro produce a suppressor cell growth factor.

Authors:  E J Fox; R G Cook; D E Lewis; R R Rich
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 3.  The T cell antigen receptor.

Authors:  M K Collins; M J Owen
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

4.  Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones.

Authors:  A Bensussan; B Tourvieille; L K Chen; J Dausset; M Sasportes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.

Authors:  T Ebihara; S Koyama; K Fukao; T Osuga
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Ion channels activated by specific Ti or T3 antibodies in plasma membranes of human T cells.

Authors:  I Pecht; A Corcia; M P Liuzzi; A Alcover; E L Reinherz
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

7.  T suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytes.

Authors:  E J Fox; D E Lewis; K P Deemer; M N ElMasry; R R Rich
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

8.  Downregulation of T cell responses by antibodies to the T cell receptor.

Authors:  S Webb; J Sprent
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

9.  Detection of T cell receptor alpha chain locus rearrangements in human antigen-specific T lymphocyte clones using a DNA probe specific for chromosome region 14q11.

Authors:  D Mathieu-Mahul; L K Chen; C J Larsen; A Bensussan
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

10.  Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).

Authors:  T Hara; S M Fu; J A Hansen
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.